Navigation Links
Cheetah Medical Announces New Management Team

NEWTON, Mass., June 4, 2013 /PRNewswire/ -- Cheetah Medical Inc., which developed and markets NICOM®, the revolutionary Non-invasive Hemodynamic Monitoring System, today announced the appointment of Chris Hutchison as President and CEO and William T. Denman , MBChB, FRCA as Chief Medical Officer.  Concurrently, the Company announced the completion of a $14.5 million financing with a prestigious group of investors including Springfield Investments, Ascension Health Ventures, MVM Life Science Partners and Robert Bosch Venture Capital.

The proceeds will be used to accelerate commercialization of NICOM in the U.S. and internationally.  NICOM is currently deployed for Goal Directed Fluid Management in over 100 hospitals in the U.S. and is widely used in OUS markets.

Mr. Hutchison has spent over 25 years in the medical device industry and has extensive general management experience, including commercializing early stage technologies in the U.S., Europe and Emerging Markets.  Prior to Cheetah he spent seven years with Covidien where he served as a General Manager in the Respiratory & Monitoring Systems and Vascular Therapies divisions.  Prior to joining Covidien, Mr. Hutchison was a U.S. Divisional President at Smiths Medical.

"There is a real need in many hospital settings for early, accurate and non-invasive hemodynamic information to better inform clinical decision making.  Since it is noninvasive, NICOM is easy and quick to deploy in critical care settings and eliminates many risks associated with older invasive methods.  He continued, "We believe that NICOM improves patient outcomes, and drives favorable healthcare economics, both of which are key considerations in the current healthcare environment."

"I am pleased to have "Pepper" Denman as our Chief Medical Officer.  He has had a distinguished career as a clinician specializing in anesthesiology, as a researcher, as an Assistant Professor at the Harvard Medical School, and was a healthcare executive for over nine years with Covidien and GE Healthcare.  He has a broad knowledge of fluid management and the critical role that it plays in patient care.

About Cheetah Medical
Cheetah Medical's NICOM Noninvasive Hemodynamic Monitoring System is based on the Company's patented and proprietary BIOREACTANCE® technology.  Clinicians use the NICOM for noninvasive, Goal Directed Fluid Management in critical and non-critical clinical environments.  NICOM is FDA cleared and has received a CE Mark.

Founded in 2000, Cheetah medical is privately held and is headquartered in Vancouver, WA.  For more information about Cheetah Medical, please visit our website at Contact: Media Contact:Jim Wagner

Steve Sandler(617) 947-8946

(508) 358-7206 ext.

SOURCE Cheetah Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. seca Launches the seca mBCA 514 - medical Body Composition Analyzer
2. Kettering Medical Center Acquires Elektas Versa HD Radiotherapy System
3. Solta Medical Announces Isolaz 2 Acne System
4. Pioneering Medical Technology Company, Optivus Proton Therapy, Inc., Celebrates 20th Anniversary
5. Cantel Medical Corp. To Hold Conference Call To Discuss Results for Its Third Quarter Ended April 30, 2013
6. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
7. CCS Medical Announces Enhanced Product Formulary
8. ViewRays Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO)
9. Hair Restoration Center Announces New Female Medical Hair Restoration
10. Kite Pharma Appoints Keith Nolop, M.D. Chief Medical Officer
11. Medical Device & Implants, LLC to exhibit at MD&M East 2013
Post Your Comments:
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):